| Literature DB >> 29157402 |
Antonio Giorgio1, Nicola De Stefano2.
Abstract
MRI is the most important tool for diagnosis and management of patients with multiple sclerosis (MS). MRI shows high sensitivity for detection of white matter lesions in the central nervous system and specificity for lesion dissemination in space and time. MRI is also used for tracking disease activity, prognostic evaluation, and monitoring the efficacy and safety of disease-modifying treatments. Nonconventional MRI measures (eg, brain atrophy) and quantitative measures of advanced MRI can capture features of MS beyond WM lesions but are not currently implemented in clinical practice. Consensus guidelines on standardized MRI acquisition protocol have been recently published.Entities:
Keywords: Atrophy; Diagnosis; Disease-modifying treatment; Lesions; MRI; Management; Multiple sclerosis; Standardized MRI protocol
Mesh:
Year: 2018 PMID: 29157402 DOI: 10.1016/j.ncl.2017.08.013
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806